Comparison of the Safety of Q8003 Versus Morphine Equivalent Doses of Its Components (Oxycodone and Morphine) in Bunionectomy Patients

Last updated: May 15, 2012
Sponsor: QRxPharma Inc.
Overall Status: Completed

Phase

3

Condition

Acute Pain

Chronic Pain

Pain

Treatment

N/A

Clinical Study ID

NCT01280331
Q8003-022
  • Ages > 18
  • All Genders

Study Summary

This is a randomized, double-blind, multicenter, repeat-dose study of fixed doses of Q8003 12 mg/8 mg given q6hr compared to morphine sulfate 24 mg and oxycodone hydrochloride 16 mg given q6hr for the management of acute moderate to severe postoperative pain for 48 hours following bunionectomy surgery.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Patient is male or female and at least 18 years of age.

  • Females must be non-pregnant, non-lactating, and practicing an acceptable method ofbirth control, or be surgically sterile or postmenopausal (amenorrhea for ≥ 12months). Non-pregnancy will be confirmed by pregnancy tests conducted at Screening andPre-treatment.

  • Patient is scheduled for bunionectomy surgery, meets the criteria of an ASA Class I toIII, and is willing to stay in the study center for at least 48 hours from the initialdose of study medication post surgery.

  • To be randomized after surgery, the patient must report moderate to severe pain (ascore of 2 or more on the 4 point Likert scale or 4 or more on the 11 point NPRSscale).

  • At least 40% of study subjects will be 60 years of age or older.

Exclusion

Exclusion Criteria:

  • In the opinion of the Investigator, has a history of pulmonary, cardiovascular (including uncontrolled hypertension), neurologic, endocrine, hepatic,gastrointestinal, or kidney disease or therapy that would jeopardize the patient'swell being by participation in this study or is mentally or emotionally unsuitable toparticipate, or unable/unwilling to comply with the study assessments.

  • Used opiates continuously (including tramadol) for more than ten days in the pastyear.

  • Hypersensitivity or poor tolerance to acetaminophen.

  • Currently receiving any medications that are not at a stable dose (the same dose for > 2 months prior to date of surgery).

  • Was dosed with another investigational drug within 30 days prior to the ScreeningVisit or has previously received treatment with Q8003.

  • Current therapy with central nervous system depressant medications that might increasethe risks of treatment with opioids (other than those used with surgical anesthesia).

  • Current evidence of alcohol abuse (regularly drinks more than 4 units of alcohol perday; 1 unit = ½ pint of beer, 1 glass of wine, or 1 ounce of spirit).

Study Design

Total Participants: 375
Study Start date:
January 01, 2011
Estimated Completion Date:
April 30, 2011

Connect with a study center

  • Investigational site

    Anaheim, California 92801
    United States

    Site Not Available

  • Investigational site

    Owings Mills, Maryland 21117
    United States

    Site Not Available

  • Investigational site

    Pasadena, Maryland 21122
    United States

    Site Not Available

  • Investigational Site

    San Antonio, Texas 78229
    United States

    Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.